1. The Impact of Over-The-Counter Lactic Acid Containing Vaginal Gels ...
23 jun 2022 · As well as maintaining a low vaginal pH which restricts the growth of non-optimal bacteria, LA also has potent anti-inflammatory properties ...
The vaginal microbiome influences a wide range of health outcomes in women, where a microbiome dominated by Lactobacillus spp. is considered optimal and associated with reduced risk of pre-term birth and acquisition of sexually transmitted ...
2. Metronidazole Gel: Uses & Side Effects - Cleveland Clinic
Metronidazole gel is a type of antibiotic that treats bacterial infections in your vagina. It doesn't treat yeast infections or viral infections.
Metronidazole gel is a type of antibiotic that treats bacterial infections in your vagina. It doesn’t treat yeast infections or viral infections.
3. Prevention and treatment of gynecological inflammation - Vinmec
Bacterial vaginosis: For this type of vaginitis, your doctor may prescribe metronidazole (Flagyl) that you take by mouth with metronidazole (MetroGel) gel or ...
Vaginitis or vaginitis is an inflammation of the vagina, which can lead to discharge, itching, and pain. The cause of gynecological infections is usually a change in the normal balance of vaginal bacteria or an infection. Decreased estrogen levels after menopause and certain skin disorders can also cause vaginitis.
4. Anti-Candida and Anti-Inflammatory Properties of a Vaginal Gel ... - MDPI
Our results show that RBG impairs C. albicans virulence and is able to reduce the inflammation in the vaginal environment.
Vaginal ecosystem is a unique environment where, in physiological conditions, lactobacilli dominate. However, pathogenic microbial species responsible for vaginitis and vaginosis can also harbor vaginal microbiota. To extend our previously published data, we analyzed here both the anti-Candida and anti-inflammatory properties of the vaginal gel formulation, Respecta® Balance Gel (RBG), commercialized as an adjuvant to treat vaginitis and vaginosis. We evaluated its activity by an in vitro model where a monolayer of A-431 vaginal epithelial cells was infected by Candida albicans in the presence of RBG or the placebo formulation (pRBG). Specifically, we tested the RBG capacity to counteract C. albicans virulence factors and their anti-inflammatory properties. Our results show that, unlike the placebo, RBG reduces C. albicans adhesion, its capacity to form hyphae and C. albicans-induced vaginal cell damage. Interestingly, both RBG and pRBG reduce LPS-induced IL-8 secretion (with RBG being the most effective), demonstrating that also the placebo retains anti-inflammatory properties. From our experimental approach, we highlighted the possible role of farnesol on such effects, but we would like to point out that lactic acid, polydextrose and glycogen too must be relevant in the actual application. In summary, our results show that RBG impairs C. albicans virulence and is able to reduce the inflammation in the vaginal environment, ultimately allowing the establishment of a balanced...
5. Gel for gynecology - IVY Medical Shop
It is spermicide-free, non-greasy and non-staining. · It has an acidic pH and good electrical conductivity. · Soluble in water. · Due to its composition, the gel ...
Gynecology gel 1 piece per 250 ml package
6. Echigin Vaginal Gel Pharmaguida, gynecology and other nutritional ...
Echigin Gel, thanks to the anti-inflammatory and immuno-stimulant properties of Echinacea purpurea and Aloe vera, is indicated as an adjuvant treatment in the ...
Echigin Vaginal Gel is a Pharmaguida's product, it belongs to the category gynecology, vaginal gel. Buy Echigin Vaginal Gel on the Pharmaguida website: linea sport, gastroenterologia, linea adulti, ginecologia, pediatria and other integratori alimentari
7. Anti-inflammatory gel for gynecology - Eureka | Patsnap
A gynecological and gel technology, which is applied in the direction of anti-inflammatory agents, medical preparations with non-active ingredients, ...
See Also冨安大貴 Birth TimeA gynecological and gel technology, which is applied in the direction of anti-inflammatory agents, medical preparations with non-active ingredients, medical raw materials derived from angiosperm subphylum, etc., can solve problems such as iodine stimulation, achieve overcoming the stimulating effect, and significantly anti-inflammatory in gynecology effect of effect
8. Get Gynecological Gel Gynecological Gel Vaginal Inflammation Private ...
Specialized solutions for women's intimate problems and many types of vaginitis.
Top choice for Asian groceries.
9. Himalaya V-Gel - Gynaecological gel for intimate infections and irritation
Gynecological Gel - powerful antimicrobial, antibacterial and antifungalHelps in treatment of all Vagina related disease. Helps in the most irritating ...
Gynecological Gel - powerful antimicrobial, antibacterial and antifungalHelps in treatment of all Vagina related disease. Helps in the most irritating issues of women's lives
10. Antibacterial gel Care for women Green World 5 pcs of applicators
The gel effectively eliminates inflammation, erosion, itching of the vagina, odor, increased yellow-white discharge and other gynecological diseases.
Product Details Antibacterial gel Care for women Green World 5 pcs of applicators - for a woman's intimate hygiene - has antibacterial, anti-inflammatory, regenerative properties, can effectively prevent and promptly solve various types of gynecological inflammation of the vagina Description 5 pcs of applicators - for a woman's intimate hygiene - has antibacterial, anti-inflammatory, regenerative
11. Application of Sol–Gels for Treatment of Gynaecological Conditions ...
Treatment of endometriosis uses various hormonal drugs, including progestins, and GnRH analogues and antagonists, aromatase inhibitors, oestrogen and ...
Approaches for effective and sustained drug delivery to the female reproductive tract (FRT) for treating a range of gynaecological conditions remain limited. The development of versatile delivery platforms, such as soluble gels (sol–gels) coupled with applicators/devices, holds considerable therapeutic potential for gynaecological conditions. Sol–gel systems, which undergo solution-to-gel transition, triggered by physiological conditions such as changes in temperature, pH, or ion composition, offer advantages of both solution- and gel-based drug formulations. Furthermore, they have potential to be used as a suitable drug delivery vehicle for other novel drug formulations, including micro- and nano-particulate systems, enabling the delivery of drug molecules of diverse physicochemical character. We provide an anatomical and physiological perspective of the significant challenges and opportunities in attaining optimal drug delivery to the upper and lower FRT. Discussion then focuses on attributes of sol–gels that can vastly improve the treatment of gynaecological conditions. The review concludes by showcasing recent advances in vaginal formulation design, and proposes novel formulation strategies enabling the infusion of a wide range of therapeutics into sol–gels, paving the way for patient-friendly treatment regimens for acute and chronic FRT-related conditions such as bacterial/viral infection control (e.g., STDs), contraception, hormone replacement therapy (HRT), infertility...
12. Gynecological Gel Antibacterial Authentic Private Area Maintenance ...
YNBC, Gynecological Gel Antibacterial Authentic Private Area Maintenance Vaginal Inflammation Gynecological Drugs 5 Pieces/box, Feminine Health Solutions, ...
Gynecological Gel Antibacterial Authentic Private Area Maintenance Vaginal Inflammation Gynecological Drugs 5 Pieces/box, Brand: YNBC, Feminine Health Solutions-Yami. 100% authentic, 30-day return guarantee, authorized retailer, low price.
13. Single-Dose, Bioadhesive Clindamycin 2% Gel for Bacterial...
A new, single-dose clindamycin vaginal gel was highly effective, with excellent safety, in women disproportionately affected by bacterial vaginosis.
l vaginosis, that is, all four Amsel's criteria, without other genital infections. Nugent scores of 7–10 were required for efficacy assessment, per updated 2019 U.S. Food and Drug Administration guidance. Patients were evaluated at screening, day 7–14, and day 21–30 (test of cure). Clinical cure was defined as resolution of three of four Amsel's criteria. Bacteriologic cure was defined as Nugent score lower than 4. Therapeutic cure was both clinical and bacteriologic cure. Primary outcome was clinical cure at the test-of-cure visit. Secondary endpoints were clinical cure at day 7–14, and bacteriologic and therapeutic cures at day 7–14 and test of cure. A sample size of 188 patients in the clindamycin group compared with 94 patients in the placebo group had 90% power to detect statistically significant difference (P=.05, 2-tailed). RESULTS: Participants were seen between July 9, 2020, and November 12, 2020. Of 307 randomized women, 56.0% were Black and 88.3% reported one or more previous bacterial vaginosis episodes. In the modified intention-to-treat population, 70.5% of patients in the clindamycin group and 35.6% in the placebo group achieved clinical cure at test of cure (primary outcome) (difference of 34.9, 95% CI 19.0–50.8), as did 77.5% of patients in the clindamycin group and 42.6% of patients in the placebo group in the per-protocol population (difference of 34.9, 95% CI 17.0–52.7). Statistically significant differences between groups were seen for all secondary...